State Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

State Street’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,898	Closed	-$242K	–	4953
2022 Q1	$242K	Buy	+3,898	New	+$239K	﹤0.01%	4313
2019 Q4	–	Sell	-39,599	Closed	-$6.04M	–	3816
2019 Q3	$6.04M	Buy	39,599 +19,384	+96%	+$3.18M	﹤0.01%	2691
2019 Q2	$2.61M	Buy	+20,215	New	+$2.4M	﹤0.01%	3134

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street's LKFT Position: Q2 2022 in Review

State Street sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2022, closing a stake of 3,898 shares — an estimated $242K sold.

State Street first reported a position in LKFT in Q2 2019 and held it in 3 quarters. The position peaked at $6.04M in Q3 2019. 82 funds tracked by Wall St. Rank hold LKFT as of Q2 2022.

State Street reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2022 after selling out during the quarter.
State Street sold 3,898 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2022, an estimated $242K.
State Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and held it in 3 quarters.
State Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $6.04M in Q3 2019.
82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.